Loading clinical trials...
Loading clinical trials...
The rate of type-2 diabetes mellitus (T2DM) is at least 2-3 times higher in persons with psychotic illnesses than in the general population. Life expectancy of individuals with psychosis is also 20-25...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Centre for Addiction and Mental Health
Collaborators
NCT06613854 · Type 2 Diabetes Mellitus (T2DM)
NCT06894212 · Schizophrenia
NCT07232537 · Chronic Kidney Disease, Type 2 Diabetes Mellitus
NCT06003036 · Schizophrenia, Schizoaffective Disorder
NCT04226898 · Schizophrenia, Schizoaffective Disorder
Centre for Addiction and Mental Health
Toronto, Ontario
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions